CYTK

Cytokinetics, Incorporated

Stock

$65.62−0.29 (−0.44%)Close Oct 1, 2026

Shareholders' equity (Q2 2026)
−$173M

Shareholders' equity (Q2 2026)	−$173M

Shareholders' equity

Period	On	Equity	YoY	Last reported in
2025	Dec 31, 2025	−$660M	—	10-K, Feb 26, 2026
2024	Dec 31, 2024	−$135M	—	10-K, Feb 27, 2025
2023	Dec 31, 2023	−$386M	—	10-K, Feb 28, 2024
2022	Dec 31, 2022	−$108M	—	10-K, Mar 1, 2023
2021	Dec 31, 2021	$244M	+115.1%	10-K, Feb 25, 2022
2020	Dec 31, 2020	$113M	—	10-K, Feb 26, 2021
2019	Dec 31, 2019	−$11M	—	10-K, Mar 4, 2020
2018	Dec 31, 2018	$26M	−76.4%	10-K, Mar 7, 2019
2017	Dec 31, 2017	$110M	+16.4%	10-K, Mar 5, 2018
2016	Dec 31, 2016	$94M	+37.6%	10-K, Mar 6, 2017
2015	Dec 31, 2015	$69M	−25.5%	10-K, Mar 3, 2016
2014	Dec 31, 2014	$92M	+69.1%	10-K, Mar 6, 2015
2013	Dec 31, 2013	$54M	−22.3%	10-K, Mar 7, 2014
2012	Dec 31, 2012	$70M	+45.5%	10-K, Mar 15, 2013
2011	Dec 31, 2011	$48M	−31.7%	10-K, Mar 13, 2012
2010	Dec 31, 2010	$71M	−30.5%	10-K, Mar 13, 2012
2009	Dec 31, 2009	$101M	+103.8%	10-K, Mar 13, 2012
2008	Dec 31, 2008	$50M	−50.2%	10-K, Mar 13, 2012
2007	Dec 31, 2007	$100M	−6.0%	10-K, Mar 13, 2012
2006	Dec 31, 2006	$106M	+44.5%	10-K, Mar 13, 2012
2005	Dec 31, 2005	$74M	−31.6%	10-K, Mar 13, 2012
2004	Dec 31, 2004	$108M	—	10-K, Mar 13, 2012
2003	Dec 31, 2003	−$92M	—	10-K, Mar 13, 2012
2002	Dec 31, 2002	−$61M	—	10-K, Mar 13, 2012
2001	Dec 31, 2001	−$37M	—	10-K, Mar 13, 2012
2000	Dec 31, 2000	−$22M	—	10-K, Mar 13, 2012
1999	Dec 31, 1999	−$9.1M	—	10-K, Mar 13, 2012